Form 4: Dong-A ST Co., Ltd. Acquires Shares in NeuroBo Pharmaceuticals, Inc.
SEC Form 4
Dong-A ST Co., Ltd. reports acquiring shares of NeuroBo Pharmaceuticals, Inc. at $3.13 per share.
Summary
- On June 23, 2024, Dong-A ST Co., Ltd. acquired 2,544,530 shares of NeuroBo Pharmaceuticals, Inc. common stock.
- The purchase price was $3.13 per share.
- Following the transaction, Dong-A ST Co., Ltd. beneficially owns 5,348,229 shares of NeuroBo Pharmaceuticals, Inc.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard disclosure of share acquisition, with no explicit positive or negative implications.
Positives
- Dong-A ST Co., Ltd.'s increased investment could signal confidence in NeuroBo Pharmaceuticals, Inc.'s future prospects.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders and major shareholders, providing transparency to the market.
Stakeholder Impact
- Shareholders may react to the increased ownership by Dong-A ST Co., Ltd.
Key Dates
| Date | Description |
|---|---|
| 06/23/2024 | Date of transaction: Dong-A ST Co., Ltd. acquired shares of NeuroBo Pharmaceuticals, Inc. |
| 06/25/2024 | Date of signature: Form 4 signed by Min Young Kim, Chief Executive Officer of Dong-A ST Co., Ltd. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.